Browsing Tag
U.S. drug pricing
2 posts
Amgen (NASDAQ: AMGN) expands TrumpRx pricing deal, offers Aimovig and Amjevita at $299
Amgen cuts U.S. drug prices for Aimovig and Amjevita under TrumpRx, citing earlier investments in Ohio and North Carolina. See what this signals for big pharma.
Trump announces second MFN pricing deal as AstraZeneca slashes drug costs for millions
AstraZeneca to offer most-favored-nation drug prices to U.S. Medicaid and invest $50B in American pharma manufacturing. Find out what it means for patients.